This inventor holds 6 USPTO granted patents and 3 published patent applications. Top assignees: Lonza Walkersville, Inc., Lonza Cologne Gmbh, Octane Biotech Inc.. Active years: 2022-2026.
Company Filing History:
6 out of 26 
4 out of 26 
4 out of 19 Years Active: 2022-2026
Title: Joseph O'Connor: Innovator in Cell Therapy Automation
Introduction
Joseph O'Connor is a prominent inventor based in Walkersville, MD (US). He has made significant contributions to the field of cell therapy, particularly in the automation of producing genetically modified immune cells. With a total of five patents to his name, O'Connor's work is paving the way for advancements in medical treatments.
Latest Patents
O'Connor's latest patents focus on end-to-end cell therapy automation. The present disclosure provides an automated method of producing genetically modified immune cells, including chimeric antigen receptor T (CAR T) cells, utilizing a fully-enclosed cell engineering system. This innovative approach aims to streamline the production process, enhancing efficiency and safety in cell therapy applications.
Career Highlights
Throughout his career, Joseph O'Connor has worked with notable companies such as Lonza Walkersville, Inc. and Lonza Cologne GmbH. His experience in these organizations has allowed him to develop and refine his expertise in cell engineering and automation technologies.
Collaborations
O'Connor has collaborated with talented individuals in his field, including Yaling Shi and Erika McAfee. These partnerships have contributed to the success of his projects and the advancement of cell therapy innovations.
Conclusion
Joseph O'Connor's contributions to cell therapy automation are noteworthy and impactful. His innovative patents and collaborations reflect his commitment to advancing medical technology. O'Connor's work continues to inspire future developments in the field of immunotherapy.